comparable U.S. digital health stock - HIMS on NYSE
"The stock is dirt cheap
There is evidence that Hims & Hers is one of the cheapest stocks on the market today. It trades at a small market cap of just $1.4 billion. Using management's revenue guidance of $255 million, that works out to a price-to-sales ratio of 5.9.""
See comment above from analyst. If they like HIMS at a 1.4 billion valuation and revenue guidance of $255 million, I imagine they will love WELL when it gets listed in the States, with a guidance of $400 million revenue, and the same 1.4 billion valuation.